Short-term administration of tibolone reduces inflammation and oxidative stress in the hippocampus of ovariectomized rats fed high-fat and high-fructose

References

• Speakman JR. The evolution of body fatness: trading off disease and predation risk. J Exp Biol. 2018;221(Suppl 1):jeb167254.
   PubMedGoogle Scholar
• Mandavia C, Pulakat L, DeMarco V, Sowers JR. Over-nutrition and metabolic cardiomyopathy. Metabolism. 2012;61(9):1205–10.
   PubMed Web of Science ®Google Scholar
• Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol. 2007;293:F1256–61.
   PubMed Web of Science ®Google Scholar
• Valliéres L, Campbell IL, Gage FH, Sawchenko PE. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci. 2002;22(2):486–92.
   PubMed Web of Science ®Google Scholar
• Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJ, Bonde S, Kokaia Z, et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci. 2006;26(38):9703–12.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao S, Zhang HL, Liu P, Liu FF, Guo YX, et al. Proinflammatory factors mediate paclitaxel-induced impairment of learning and memory. Mediators Inflamm. 2018;2018:3941840.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iglesias N, Sierra A, Valero J. Rewiring of memory circuits: connecting adult newborn neurons with the help of microglia. Front Cell Dev Biol. 2019;7(24).
   PubMedGoogle Scholar
• Mahdi O, Baharuldin MTH, Nor NHM, Chiroma SM, Jagadeesan S, Moklas MAM. Chemicals used for the induction of Alzheimer’s disease-like cognitive dysfunctions in rodents. Biomed Res Ther. 2019;6(11):3460–84.
   Web of Science ®Google Scholar
• Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, et al. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J Alzheimer's Dis. 2011;26(3):495–505.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab. 2006;8(5):538–54.
   PubMed Web of Science ®Google Scholar
• Silva-Vial R. Menopausia y terapia de reemplazo hormonal. Rev Med Clin Las Condes. 2003;14:1–11.
   Google Scholar
• Crespo-Castrillo A, Garcia-Segura LM, Arevalo MA. The synthetic steroid tibolone exerts sex-specific regulation of astrocyte phagocytosis under basal conditions and after an inflammatory challenge. J Neuroinflammation. 2020;17(1):37.
   PubMed Web of Science ®Google Scholar
• Pinto-Almazán R, Rivas-Arancibia S, Farfán-García ED, Rodríguez-Martínez E, Guerra-Araiza C. Neuroprotective effects of tibolone against oxidative stress induced by ozone exposure. Rev Neurol. 2014;58(10):441–9.
   PubMed Web of Science ®Google Scholar
• Farfán-García ED, Castillo-Hernández MC, Pinto-Almazán R, Rivas-Arancibia S, Guerra-Araiza CH. Tibolone prevents oxidation and ameliorates cholinergic deficit induced by ozone exposure in the male rat hippocampus. Neurochem Res. 2014;39:1776–86.
   PubMed Web of Science ®Google Scholar
• Estrada-Cruz NA, Almanza-Pérez JC, Fortis-Barrera Á, Gallardo JM, Manuel-Apolinar L, Segura-Uribe JJ, et al. Acute administration of tibolone prevents oxidative stress in ovariectomized rats fed high-fat-and-fructose diet. Exp Clin Endocrinol Diabetes. 2019;127(6):396–404.
   PubMed Web of Science ®Google Scholar
• Landgren MB, Bennink HJ, Helmond FA, Engelen S. Dose-response analysis of effects of tibolone on climacteric symptoms. BJOG. 2002;109(10):1109–14.
   PubMed Web of Science ®Google Scholar
• Lv C, Zhang W, Tan X, Shang X, Găman MA, Salem H, et al. The effect of tibolone treatment on lipid profile in women: a systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacol Res. 2021;169:105612.
   PubMed Web of Science ®Google Scholar
• Waynforth HB, Flecknell PA. Experimental and surgical technique in the rat. London: Academic Press; 1992.
   Google Scholar
• Henle T, Deppisch R, Beck W, Hergesell O, Hänsch GM, Ritz E. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant. 1999;14(8):1968–75.
   PubMed Web of Science ®Google Scholar
• Münch G, Mayer S, Michaelis J, Hipkiss AR, Riederer P, Müller R, et al. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide. Biochim Biophys Acta. 1997;1360(1):17–29.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman's reagent. Anal Biochem. 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27(3):502–22.
   PubMed Web of Science ®Google Scholar
• Lawrence RA, Burk RF. Reprint of “glutathione peroxidase activity in selenium-deficient Rat liver”. Biochem Biophys Res Commun. 2012;425(3):503–9.
   PubMed Web of Science ®Google Scholar
• Neto NI, Rodrigues ME, Hachul AC, Moreno MF, Boldarine VT, Ribeiro EB, et al. A hyperlipidic diet combined with short-term ovariectomy increases adiposity and hyperleptinemia and decreases cytokine content in mesenteric adipose tissue. Mediators Inflamm. 2015;2015:923248.
   PubMed Web of Science ®Google Scholar
• Calvo-Ochoa E, Hernández-Ortega K, Ferrera P, Morimoto S, Arias C. Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus. J Cereb Blood Flow Metab. 2014;34(6):1001–8.
   PubMed Web of Science ®Google Scholar
• Kim KW, Sohn JW, Kohno D, Xu Y, Williams K, Elmquist JK. SF-1 in the ventral medial hypothalamic nucleus: a key regulator of homeostasis. Mol Cell Endocrinol. 2011;336(1-2):219–23.
   PubMed Web of Science ®Google Scholar
• Hart-Unger S, Korach KS. Estrogens and obesity: is it all in our heads? Cell Metab. 2011;14(4):435–6.
   PubMed Web of Science ®Google Scholar
• Pedram A, Razandi M, Blumberg B, Levin ER. Membrane and nuclear estrogen receptor a collaborate to suppress adipogenesis but not triglyceride content. FASEB J. 2016;30(1):230–40.
   PubMed Web of Science ®Google Scholar
• Milewicz A, Tworowska U, Demissie M. Menopausal obesity—myth or fact? Climacteric. 2001;4(4):273–83.
   PubMedGoogle Scholar
• Feigelson HS, Jonas CR, Teras LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomark Prev. 2004;13(2):220–4.
   PubMed Web of Science ®Google Scholar
• Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12(2):105–12.
   PubMed Web of Science ®Google Scholar
• Toledano-Gasca A, Álvarez MI, Toledano-Díaz A, Rodríguez-Arellano JJ. [New concepts on the functionality of the nervous system: The revolution of the glial cells. II. glial responses keys in the pathogenesis and treatment of diseases of SN]. An Real Acad Farm. 2016;82(1):51–67. Spanish.
   Google Scholar
• Martín MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014;15:1036–52.
   PubMed Web of Science ®Google Scholar
• Björkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006;260:493–508.
   PubMed Web of Science ®Google Scholar
• Dasari B, Prasanthi JR, Marwarha G, Singh BB, Ghribi O. The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol. 2010;10(22).
   PubMedGoogle Scholar
• Brooks SW, Dykes AC, Schreurs BG. A high-cholesterol diet increases 27-hydroxycholesterol and modifies estrogen receptor expression and neurodegeneration in rabbit hippocampus. J Alzheimer's Dis. 2017;56(1):185–196.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lv C, An Y, Liu Q, Rong H, Tao L, et al. Increased levels of 27-hydroxycholesterol induced by dietary cholesterol in brain contribute to learning and memory impairment in rats. Mol Nutr Food Res. 2018;62(3).
   Web of Science ®Google Scholar
• Villanueva LA, Ortega R, Morimoto S, Villanueva S, Arranz C. Efectos de la tibolona sobre el metabolismo de lípidos, glucosa y secreción de insulina en mujeres posmenopáusicas. Ginecol Obstet Mex. 1999;67(10):473–7. Spanish.
   PubMedGoogle Scholar
• Gutiérrez-Nava A, Mayorga-Reyes L. La era post-genómica en biomedicina. Rev Mex Cienc Farm. 2011;42(2):7–13. Spanish.
   Google Scholar
• Wang S, Wang B, Feng Y, Mo M, Du F, Li H, Yu X. 17β-estradiol ameliorates light-induced retinal damage in sprague-dawley rats by reducing oxidative stress. J Mol Neurosci. 2015;55(1):141–51.
   PubMed Web of Science ®Google Scholar
• Stranahan AM, Cutler RG, Button C, Telljohann R, Mattson MP. Diet-induced elevations in serum cholesterol are associated with alterations in hippocampal lipid metabolism and increased oxidative stress. J Neurochem. 2011;118(4):611–5.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fu X, Lan N, Li S, Zhang J, Wang S, et al. Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav Brain Res. 2014;267:178–88.
   PubMed Web of Science ®Google Scholar
• Val-Laillet D, Layec S, Guerin S, Meurice P, Malbert CH. Changes in brain activity after a diet-induced obesity. Obesity. 2011;19(4):749–56.
   PubMed Web of Science ®Google Scholar
• Carvalho AN, Marques C, Guedes RC, Castro-Caldas M, Rodrigues E, vanHorssen J, et al. S-glutathionylation of Keap1: a new role for glutathioneS-transferase pi in neuronal protection. FEBS Lett. 2016;590(10):1455–66.
   PubMed Web of Science ®Google Scholar
• Bloch-Damti A, Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signaling. 2005;7(11-12):1553–67.
   PubMed Web of Science ®Google Scholar
• Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Mendoza-Núñez VM. Efecto de la terapia hormonal con estrógenos en el estrés oxidativo y la calidad de vida en mujeres posmenopáusicas. Ginecol Obstet Mex. 2013;81:11–22. Spanish.
   PubMedGoogle Scholar
• Dilek M, Nazıroğlu M, Oral HB, Övey İS, Küçükayaz M, Mungan MT, et al. Melatonin modulates hippocampus NMDA receptors, blood and brain oxidative stress levels in ovariectomized rats. J Membr Biol. 2010;233(1-3):135–42.
   PubMed Web of Science ®Google Scholar
• Patki G, Solanki N, Atrooz F, Allam F, Salim S. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res. 2013;1539:73–86.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease—a double-edged sword. Neuron. 2002;35(3):419–32.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21(3):383–421.
   PubMed Web of Science ®Google Scholar
• Heneka MT, O’Banion MK. Inflammatory processes in Alzheimer’s disease. J Neuroimmunol. 2007;184(1-2):69–91.
   PubMed Web of Science ®Google Scholar
• Herrmann O, Tarabin V, Suzuki S, Attigah N, Coserea I, Schneider A, et al. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab. 2003;23:406–15.
   PubMed Web of Science ®Google Scholar
• Crespo-Castrillo A, Yanguas-Casás N, Arevalo MA, Azcoitia I, Barreto GE, Garcia-Segura LM. The synthetic steroid tibolone decreases reactive gliosis and neuronal death in the cerebral cortex of female mice after a stab wound injury. Mol Neurobiol. 2018;55(11):8651–67.
   PubMed Web of Science ®Google Scholar
• Vila N, Castillo J, Dávalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000;31(10):2325–9.
   PubMed Web of Science ®Google Scholar
• Cuenca-López MD, Brea D, Segura T, Galindo MF, Antón-Martínez D, Agulla J, et al. La inflamación como agente terapéutico en el infarto cerebral: respuesta inflamatoria celular y mediadores inflamatorios. Rev Neurol. 2010;50(6):349–59. Spanish.
   PubMedGoogle Scholar
• Vitale C, Cornoldi A, Gebara O, Silvestri A, Wajngarten M, Cerqeutani E, et al. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. Menopause. 2005;12(5):552–8.
   PubMed Web of Science ®Google Scholar
• De Medeiros AR, Lamas AZ, Caliman IF, Dalpiaz PL, Firmes LB, de Abreu GR, et al. Tibolone has anti-inflammatory effects in estrogen-deficient female rats on the natriuretic peptide system and TNF-alpha. Regul Pept. 2012;179(1-3):55–60.
   PubMedGoogle Scholar
• Aguayo-Cerón KA, Morales-González JA, Gutiérrez-Iglesias G, Parra-Barrera A, Jiménez-Zamarripa CA, Ocharán-Hernández ME, et al. Efecto regulador de tibolona sobre la actividad antiinflamatoria del macrófago. Rev Mex Ing Biomed. 2019;40(3):e201833. Spanish.
   Google Scholar
• Cai D, Liu T. Inflammatory cause of metabolic syndrome via brain stress and NF-κB. Aging. 2012;4(2):98–115.
   PubMedGoogle Scholar
• Verheul HA, van Iersel ML, Delbressine LP, Kloosterboer HJ. Selective tissue distribution of tibolone metabolites in mature ovariectomized female cynomolgus monkeys after multiple doses of tibolone. Drug Metab Dispos. 2007;35(7):1105–11.
   PubMed Web of Science ®Google Scholar
• Del Río JP, Molina S, Hidalgo-Lanussa O, Garcia-Segura LM, Barreto GE. Tibolone as hormonal therapy and neuroprotective agent. Trends Endocrinol Metab. 2020;31(10):742–59.
   PubMed Web of Science ®Google Scholar
• Scudiero R, Verderame M. Gene expression profile of estrogen receptors alpha and beta in rat brain during aging and following high fat diet. C R Biol. 2017;340(8):372–8.
   PubMed Web of Science ®Google Scholar
• Ávila-Rodríguez M, Garcia-Segura LM, Hidalgo-Lanussa O, Baez E, González J, Barreto GE. Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression. Mol Cell Endocrinol. 2016;433:35–46.
   PubMed Web of Science ®Google Scholar
• Acaz-Fonseca E, Ávila-Rodríguez M, Garcia-Segura LM, Barreto GE. Regulation of astroglia by gonadal steroid hormones under physiological and pathological conditions. Prog Neurobiol. 2016;144:5–26.
   PubMed Web of Science ®Google Scholar
• Arévalo MA, Santos-Galindo M, Lagunas N, Azcoitia I, Garcia-Segura LM. Selective estrogen receptor modulators as brain therapeutic agents. J Mol Endocrinol. 2011;46(1):R1–9.
   PubMed Web of Science ®Google Scholar
• Hidalgo-Lanussa O, Ávila-Rodríguez M, Báez-Jurado E, Zamudio J, Echeverria V, Garcia-Segura LM, Barreto GE. Tibolone reduces oxidative damage and inflammation in microglia stimulated with palmitic acid through mechanisms involving estrogen receptor beta. Mol Neurobiol. 2018;55(7):5462–5477. doi:10.1007/s12035-017-0777-y
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ. Historical milestones in the development of tibolone (Livial®). Climacteric. 2011;14(6):609–21.
   PubMed Web of Science ®Google Scholar
• Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav. 2014;66(4):602–18.
   PubMed Web of Science ®Google Scholar
• Reed MJ, Kloosterboer HJ. Tibolone: a selective tissue estrogenic activity regulator (STEAR). Maturitas. 2004;48(Suppl 1):4–6.
   Google Scholar